Intravenous fluids are sterile solutions delivered directly into a vein, and they remain one of the most common medical interventions worldwide, given to the majority of hospitalized patients at some point during their stay. The concept sounds simple: replace or supplement the water, salts, and other substances the body needs. But the choice of which fluid, how much, and how fast turns out to be remarkably consequential, with large trials in recent years reshaping decades-old assumptions about what works best and what causes harm.
How Fluid Actually Moves Through the Body
When a bag of standard crystalloid solution drips into your vein, only about a fifth of that volume stays in your bloodstream. The remaining roughly 80% filters out of the blood vessels and settles into the spaces between your cells, called the interstitial space.1PubMed Central. Intravenous fluid therapy: essential components and key considerations This means that if you receive a liter of saline, your blood volume gets only about 200 milliliters of lasting expansion. The rest quietly pads the tissues throughout your body, which is why patients who receive large volumes of IV fluid often develop visible swelling.
The process is more nuanced than a simple two-compartment split. Research using volume kinetics shows that small infusions of a few hundred milliliters stay almost entirely in the plasma. Intermediate volumes spread into a “fast-exchange” interstitial space that equilibrates within about 30 minutes. Only when you push past roughly 1.3 to 1.5 liters does a slower-exchange reservoir open up, acting as a buffer against overwhelming the bloodstream.2Annals of Intensive Care. Where does the fluid go? This tiered distribution explains why modest fluid boluses can meaningfully raise blood pressure while very large volumes increasingly just waterlog tissues.
The Main Categories of IV Fluids
IV fluids fall into two broad families: crystalloids and colloids. Crystalloids are solutions of water and small dissolved molecules like sodium, chloride, potassium, and sometimes buffers like lactate or acetate. Because the dissolved particles are small, they pass freely through capillary walls, which is why most of the fluid leaves the bloodstream quickly. Colloids contain larger molecules, either natural proteins like albumin or synthetic starches and gelatins, that are too big to easily escape through vessel walls. The idea behind colloids is that they pull water into the bloodstream by osmotic pressure and stay there longer, but whether that theoretical advantage translates into better patient outcomes has been debated for decades.
A massive Cochrane review pooling 69 studies and over 30,000 patients found that colloids, including starches, dextrans, gelatins, and albumin, offered no meaningful survival benefit over crystalloids in critically ill patients.3The Cochrane Database of Systematic Reviews. Colloids versus crystalloids for fluid resuscitation in critically ill patients For most situations, cheaper and simpler crystalloids do the job just as well.
Normal Saline and Its Surprisingly Abnormal Chemistry
Normal saline, a 0.9% sodium chloride solution, has been the workhorse of IV fluid therapy for over a century. The name “normal” is misleading. Its chloride concentration of 154 millimoles per liter is substantially higher than the roughly 100 to 110 millimoles per liter found in your blood plasma. When large volumes are given, the chloride load can push the blood toward an acidotic state, a condition called hyperchloremic acidosis.4BJA: British Journal of Anaesthesia. Physiological effects of hyperchloraemia and acidosis For a single liter given to someone mildly dehydrated, this rarely matters. But in critically ill patients receiving many liters, the chloride excess has been linked to reduced kidney blood flow and other complications.
This concern led to the development of “balanced” crystalloids like Ringer’s lactate and Plasma-Lyte, which more closely match the electrolyte profile of blood plasma. The landmark SMART trial, involving nearly 16,000 critically ill adults, found that balanced crystalloids reduced the rate of major kidney problems compared to saline, with roughly 14% experiencing a major adverse kidney event versus about 15% on saline.5PubMed Central. Balanced Crystalloids versus Saline in Critically Ill Adults The difference in 30-day mortality leaned toward balanced fluids but did not reach conventional statistical thresholds in the overall population.
The gap widened considerably when researchers looked specifically at patients with sepsis. In that subgroup from the same trial, 30-day mortality was about 26% with balanced crystalloids versus 31% with saline, and the kidney complication rate was also lower.6PubMed Central. Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial These findings have shifted practice in many intensive care units toward using balanced solutions as the default, though normal saline still has specific uses, such as when patients need sodium loading or when compatibility with certain medications is a concern.
When Colloids Still Have a Role
Even though crystalloids dominate everyday fluid therapy, albumin retains specific niches where evidence supports its use. Liver disease is the clearest example. For patients undergoing large-volume paracentesis, experiencing spontaneous bacterial peritonitis, or developing hepatorenal syndrome, albumin has moderate-to-strong evidence behind it and is often considered first-line rather than a luxury add-on.7PubMed. Albumin: a comprehensive review and practical guideline for clinical use In sepsis and septic shock, albumin sometimes appears as a second-line option alongside crystalloids, though the evidence there is weaker.
Synthetic colloids, particularly hydroxyethyl starch (HES), have a much darker track record. A meta-analysis of over 10,000 critically ill patients found that HES was associated with increased mortality, a higher rate of kidney failure, and greater need for dialysis compared to other fluids.8JAMA. Association of Hydroxyethyl Starch Administration With Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume Resuscitation The same Cochrane review that showed no survival difference between colloids and crystalloids overall found that starches specifically increased the need for blood transfusions and kidney replacement therapy.9The Cochrane Database of Systematic Reviews. Colloids versus crystalloids for fluid resuscitation in critically ill patients Regulatory agencies in Europe have restricted or suspended HES products, and their use has declined sharply in many countries.
Hypertonic Solutions for Brain Emergencies
Not all IV fluids are designed to hydrate. Hypertonic saline, typically in 3% or even 23.4% concentrations, serves a specialized purpose: pulling water out of swollen brain tissue to reduce dangerous pressure inside the skull. The principle is osmotic. Because sodium chloride has a very high reflection coefficient at the blood-brain barrier, it stays in the bloodstream and draws cellular water along a concentration gradient, effectively shrinking swollen brain tissue.10Neurotherapeutics. The Medical Management of Cerebral Edema: Past, Present, and Future Therapies
Hypertonic saline also has an advantage over the traditional alternative, mannitol, in that it does not cause the same degree of dehydration through urinary losses. In fact, it tends to expand blood volume, which can be helpful in patients who are both brain-swollen and hemodynamically unstable from trauma or sepsis.11Neurotherapeutics. The Medical Management of Cerebral Edema: Past, Present, and Future Therapies Guidelines for neurocritical care suggest that hyperosmolar therapy can reduce intracranial pressure elevations across multiple conditions, including traumatic brain injury, stroke, and bleeding around the brain, though the effect on long-term neurological outcomes remains unclear.12PubMed Central. Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients
Why Hypotonic Fluids Fell Out of Favor for Children
For decades, hospitalized children routinely received hypotonic maintenance fluids, solutions with a lower sodium concentration than plasma. The reasoning seemed logical: children need “free water” for ongoing metabolic needs. The problem is that sick, stressed, or post-surgical children often produce excess antidiuretic hormone, which prevents them from excreting extra water. Combine that with a low-sodium IV fluid, and sodium levels in the blood can drop dangerously low.
A meta-analysis in Pediatrics found that children receiving hypotonic IV fluids had more than double the risk of developing low sodium levels and over five times the risk of severe hyponatremia compared to those on isotonic fluids.13Pediatrics. Isotonic Versus Hypotonic Maintenance IV Fluids in Hospitalized Children: A Meta-Analysis Severe hyponatremia can cause brain swelling, seizures, and in rare cases death or permanent neurological damage, particularly in postoperative patients.14PubMed Central. Hospital-Acquired Hyponatremia in Pediatric Patients: A Review of the Literature This evidence prompted a broad shift in pediatric practice toward isotonic maintenance fluids as the standard, a change that many hospitals adopted between roughly 2015 and 2020.15PubMed. Comparison of isotonic and hypotonic intravenous maintenance fluids: a randomized clinical trial
The Problem of Too Much Fluid
Fluid resuscitation saves lives in the acute phase of shock, but there is a tipping point. In critically ill patients, especially those with sepsis, capillary walls become leaky. IV fluid that would normally stay partly in the bloodstream instead pours into the tissues, causing edema that impairs oxygen delivery, compresses small blood vessels, and disrupts normal organ function.16PubMed Central. Fluid overload in the ICU: evaluation and management A positive fluid balance at 72 hours into sepsis treatment has been linked to significantly increased mortality.17PubMed. Tissue Edema, Fluid Balance, and Patient Outcomes in Severe Sepsis: An Organ Systems Review
Recognizing this, intensive care medicine has moved toward a phased approach often called the ROSE concept: Resuscitation, Optimization, Stabilization, and Evacuation. Early on, aggressive fluid delivery is appropriate. As the patient stabilizes, the focus shifts to conservative dosing and eventually to actively removing excess fluid to restore normal volume.18PubMed. The ROSE concept: modern fluid management in intensive care medicine The challenge is knowing exactly when to transition between phases, which brings up a measurement problem that the field has grappled with for years.
Figuring Out Who Actually Needs More Fluid
For decades, clinicians relied on central venous pressure, the pressure measured at the entrance to the heart, to decide whether a patient needed more fluid. The logic seemed sound: low pressure means low volume, so give more. But study after study showed that central venous pressure and similar static measurements are unreliable predictors of whether a patient’s heart will actually pump more blood in response to a fluid bolus.19PubMed Central. Prediction of fluid responsiveness: an update 20PubMed. Monitoring volume and fluid responsiveness: from static to dynamic indicators
The shift has been toward dynamic tests: observing what happens to heart output when you briefly change something. One popular method involves watching how pulse pressure varies with each breath in a patient on a ventilator, since mechanical breaths create predictable swings in blood return to the heart. Another is the passive leg raise, where lifting a patient’s legs temporarily shuttles several hundred milliliters of venous blood toward the heart, mimicking a fluid bolus without actually giving any fluid. If cardiac output rises meaningfully during the leg raise, the patient is likely to benefit from more fluid. If it does not, additional fluid will probably just cause edema.
Fluid Strategy During Surgery
The operating room presents its own fluid dilemmas. Surgeons and anesthesiologists have long debated whether patients do better with generous (“liberal”) or limited (“restrictive”) fluid strategies during major operations. A network meta-analysis comparing these approaches with a third option, goal-directed therapy that uses real-time monitoring to guide each fluid bolus, found that goal-directed approaches appeared to reduce perioperative complications compared to both liberal and restrictive strategies, though the overall evidence quality was low.21PubMed Central. Restricted Versus Liberal Versus Goal-Directed Fluid Therapy for Non-vascular Abdominal Surgery: A Network Meta-Analysis and Systematic Review
A randomized trial comparing goal-directed therapy directly against a restrictive approach in major abdominal surgery found no significant difference in complications, despite the goal-directed group receiving about 50% more fluid during the operation.22PubMed. Goal-directed hemodynamic therapy versus restrictive normovolemic therapy in major open abdominal surgery: A randomized controlled trial The takeaway for patients: the exact volume matters less than whether it is guided by what your body is actually telling the monitors in real time.
Vein Access and What Determines Which Fluids Go Where
Not every IV fluid can safely flow through a standard hand or forearm vein. The concentration, or osmolality, of the solution matters enormously. Peripheral veins tolerate solutions up to a certain concentration before the vessel lining starts to become inflamed, a condition called phlebitis. Experimental work shows that the tolerance threshold drops the longer the infusion lasts: peripheral veins can handle solutions around 820 milliosmoles per kilogram for an eight-hour infusion but only about 550 for a 24-hour one.23PubMed. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells
Parenteral nutrition, which can exceed 1,000 milliosmoles per liter, is a common example of a solution too concentrated for small veins. A study of pediatric patients found that solutions above that threshold roughly doubled the rate of infiltration and significantly increased the combined rate of phlebitis or infiltration.24PubMed. Maximum tolerated osmolarity for peripheral administration of parenteral nutrition in pediatric patients This is why concentrated nutrition formulas and certain medications typically require a central venous catheter, a larger line threaded into a big vein near the heart where high blood flow rapidly dilutes the solution.
Interestingly, 3% hypertonic saline, which has an osmolality well above normal plasma, can be given peripherally with a relatively low complication rate. A systematic review found that the incidence of phlebitis was about 6% and infiltration about 3% when 3% saline was infused through peripheral IVs.25PubMed. The safety of intravenous peripheral administration of 3% hypertonic saline: A systematic review and meta-analysis This finding has practical importance in emergency settings where a central line may not be available and a patient with dangerous brain swelling needs hyperosmolar therapy immediately.
Electrolyte Additives
IV fluids frequently serve as vehicles for electrolyte correction, most commonly potassium. Low potassium is dangerous because it predisposes the heart to abnormal rhythms, and oral replacement is slow. Concentrated potassium chloride infusions, typically 20 milliequivalents in 100 milliliters of saline run over one hour, can raise serum potassium by about 0.25 millimoles per liter per dose. A study of over 1,300 such infusions found this approach to be relatively safe, with no life-threatening arrhythmias, though mild elevations above target occurred occasionally.26JAMA Internal Medicine. Rapid Correction of Hypokalemia Using Concentrated Intravenous Potassium Chloride Infusions The key is continuous cardiac monitoring and frequent lab checks, which is why aggressive potassium replacement is an ICU intervention rather than a general ward procedure.
The Wellness IV Trend
Outside of hospitals, IV hydration spas have become a growing wellness trend, offering drips marketed to cure hangovers, boost immunity, or “detoxify” the body. A JAMA investigation noted that virtually all IV hydration spa websites make health claims, but 99% of them cited no scientific references to support those claims.27JAMA. IV Hydration Spas Are Gaining Popularity, but Are They Safe? A review of IV vitamin therapy similarly concluded that there is no solid evidence supporting benefits for healthy individuals; the supposed effects on energy, immunity, or skin health are anecdotal rather than backed by randomized trials.28PubMed Central. To IV or Not to IV: The Science Behind Intravenous Vitamin Therapy
The risks, while generally low for a single session, are not zero. Any time a needle enters a vein, there is a small chance of infection, phlebitis, or air embolism. Facilities operating outside the regulated medical system may not maintain the same sterility standards or staffing qualifications as a hospital. For someone who is healthy and well-hydrated, the kidneys are perfectly capable of managing water and electrolyte balance through drinking fluids, and no IV drip has been shown to outperform a glass of water and a meal for general recovery.
A Brief History Worth Knowing
IV fluid therapy has a surprisingly dramatic origin story. During the cholera pandemic of 1832 in Britain, a physician named William O’Shaughnessy analyzed the blood of cholera patients and discovered they were losing enormous amounts of water, salt, and bicarbonate. His colleague Thomas Latta then attempted to replace those losses by infusing saline solutions directly into the veins of dying patients, observing striking and immediate improvements in people who had been moribund minutes before.29PubMed Central. The History of Intravenous and Oral Rehydration and Maintenance Therapy of Cholera and Non-Cholera Dehydrating Diarrheas 30PubMed. The controversial and short-lived early use of rehydration therapy for cholera
Remarkably, the medical establishment largely abandoned this approach after the immediate outbreak subsided. It would take another century before IV fluid therapy became a reliable and routine intervention, delayed by the need for sterile manufacturing, safe vascular access devices, and a better understanding of electrolyte physiology. That gap between a correct idea and its widespread implementation is one of the more painful examples of how slowly medicine sometimes translates discoveries into practice.
Supply Chain Fragility
IV fluids seem like a commodity that should always be available, but their supply chain is surprisingly vulnerable. When Hurricane Maria devastated Puerto Rico in 2017, it knocked out a major manufacturing facility that supplied much of the United States. One large hospital system saw its supply of small-volume IV fluid bags drop from over 1,600 in October 2017 to zero in November, a shortage that persisted for months. Supply did not begin recovering until June 2018.31PubMed Central. Disruption of normal saline supply chain due to a disaster: an analysis of the impact of normal saline shortage on anesthesia practice in a large hospital system and models toward resiliency Anesthesia providers adapted by switching to alternatives like Plasma-Lyte and lactated Ringer’s, but the episode exposed how concentrated the manufacturing base for such a basic product really is.
Environmental Footprint of IV Therapy
Every IV setup generates plastic waste: the bag, the tubing, the connectors, the packaging. Intensive care units in particular go through enormous quantities. One hospital found that by extending the allowable use time of IV administration sets rather than replacing them on a rigid schedule, they eliminated over 880 replacement sets, 182 kilograms of plastic waste, and 96 nursing hours in a single year.32PubMed. Reducing plastic waste in intensive care from longer use of intravenous administration and invasive monitoring sets: A before-and-after study Another initiative estimated that thoughtful IV fluid stewardship, avoiding unnecessary bags, could reduce carbon dioxide emissions by about 113 kilograms and eliminate 14 kilograms of plastic waste per 1,000 patients.33PubMed. Stewardship of Intravenous Fluids During Shortage and Beyond These numbers may seem modest individually, but multiplied across millions of hospital admissions per year, the cumulative environmental impact is substantial. Reducing unnecessary fluid orders serves both the patient and the planet.